
ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.
Publication
, Journal Article
Orozco, JIJ; Le, J; Baker, JL; Marzese, DM; DiNome, ML
Published in: Ann Surg Oncol
October 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
October 2022
Volume
29
Issue
10
Start / End Page
6415 / 6416
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoadjuvant Therapy
- Humans
- Female
- Breast Neoplasms
- Axilla
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Orozco, J. I. J., Le, J., Baker, J. L., Marzese, D. M., & DiNome, M. L. (2022). ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete. Ann Surg Oncol, 29(10), 6415–6416. https://doi.org/10.1245/s10434-022-12327-0
Orozco, Javier I. J., Julie Le, Jennifer L. Baker, Diego M. Marzese, and Maggie L. DiNome. “ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.” Ann Surg Oncol 29, no. 10 (October 2022): 6415–16. https://doi.org/10.1245/s10434-022-12327-0.
Orozco JIJ, Le J, Baker JL, Marzese DM, DiNome ML. ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete. Ann Surg Oncol. 2022 Oct;29(10):6415–6.
Orozco, Javier I. J., et al. “ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.” Ann Surg Oncol, vol. 29, no. 10, Oct. 2022, pp. 6415–16. Pubmed, doi:10.1245/s10434-022-12327-0.
Orozco JIJ, Le J, Baker JL, Marzese DM, DiNome ML. ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete. Ann Surg Oncol. 2022 Oct;29(10):6415–6416.

Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
October 2022
Volume
29
Issue
10
Start / End Page
6415 / 6416
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoadjuvant Therapy
- Humans
- Female
- Breast Neoplasms
- Axilla
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis